Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Medication for attention deficit-hyperactivity disorder and criminality.

Thomas E, Bhurawala H, Liu A.

N Engl J Med. 2013 Feb 21;368(8):775. doi: 10.1056/NEJMc1215531#SA1. No abstract available.

PMID:
23425179
2.

Medication for attention deficit-hyperactivity disorder and criminality.

Cohen D.

N Engl J Med. 2013 Feb 21;368(8):775-6. doi: 10.1056/NEJMc1215531#SA2. No abstract available.

PMID:
23425180
3.

Medication for attention deficit-hyperactivity disorder and criminality.

Lichtenstein P, Larsson H.

N Engl J Med. 2013 Feb 21;368(8):776. doi: 10.1056/NEJMc1215531. No abstract available.

4.

Medication for attention deficit-hyperactivity disorder and criminality.

Lichtenstein P, Halldner L, Zetterqvist J, Sjölander A, Serlachius E, Fazel S, Långström N, Larsson H.

N Engl J Med. 2012 Nov 22;367(21):2006-14. doi: 10.1056/NEJMoa1203241.

5.
6.

[The significance of attention-deficit hyperactivity disorder for the future of the child and the young].

Penttilä J, Rintahaka P, Kaltiala-Heino R.

Duodecim. 2011;127(14):1433-9. Review. Finnish.

PMID:
21888044
7.

An adolescent who abruptly stops his medication for attention-deficit hyperactivity disorder.

Stein MT, Shafer MA, Elliott GR, Levine S.

J Dev Behav Pediatr. 1999 Apr;20(2):106-10. No abstract available.

PMID:
10219689
8.

Medication for attention deficit hyperactivity disorder: commentary and response.

Faigel HC, Heiligenstein E.

J Am Coll Health. 1996 Jul;45(1):40-1; discussion 41-2. No abstract available.

PMID:
8708265
9.

Managing stimulant medication for attention-deficit/hyperactivity disorder: an update.

Wender EH.

Pediatr Rev. 2002 Jul;23(7):234-6. Review. No abstract available.

PMID:
12093933
10.

The burden of untreated ADHD among adults: the role of stimulant medication.

Goksøyr PK, Nøttestad JA.

Addict Behav. 2008 Feb;33(2):342-6. Epub 2007 Sep 11.

PMID:
17920777
11.

Attention-deficit hyperactivity disorder diagnosis and treatment. Separating myth from substance.

Barzman DH, Fieler L, Sallee FR.

J Leg Med. 2004 Mar;25(1):23-38. Review. No abstract available.

PMID:
15208788
12.

Pharmacologic treatment of attention deficit hyperactivity disorder.

Greenhill LL.

Psychiatr Clin North Am. 1992 Mar;15(1):1-27. Review.

PMID:
1347936
13.
14.

Advances in the pharmacotherapy of attention-deficit/hyperactivity disorder.

Kollins SH, March JS.

Biol Psychiatry. 2007 Nov 1;62(9):951-3. Review. No abstract available.

PMID:
17950067
15.

Long-term treatment of children and adolescents with attention-deficit/hyperactivity disorder (ADHD).

Hechtman L.

Curr Psychiatry Rep. 2006 Oct;8(5):398-408. Review.

PMID:
16968623
16.

Mechanism of action of stimulants in attention-deficit/hyperactivity disorder.

Stahl SM.

J Clin Psychiatry. 2010 Jan;71(1):12-3. doi: 10.4088/JCP.09bs05890pur. Review. No abstract available.

17.

[Attention-Deficit Hyperactivity Disorder].

DuPont RL.

Essent Psychopharmacol. 2005;6(5):iv. No abstract available.

PMID:
16222908
18.
19.

Clinical management of attention deficit hyperactivity disorder.

Voeller KK.

J Child Neurol. 1991;6 Suppl:S51-67. Review.

PMID:
1672134
20.

Adolescent outcome of hyperactive children treated with stimulants in childhood: a review.

Hechtman L.

Psychopharmacol Bull. 1985;21(2):178-91. Review. No abstract available.

PMID:
2860690
Items per page

Supplemental Content

Write to the Help Desk